Protocol SAKK 77/06 and SASL 23 Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma A multicenter phase II trial To demonstrate antitumor activity of continuous sunitinib (Sutent®) treatment in patients with unresectable hepatocellular carcinoma.

• Country None
• organs None
• Specialty None

Neoadjuvant radiotherapy and capecitabine with or without panitumumab in patients with advanced, K-ras unmutated rectal cancer. A randomized multicenter phase II trial To assess the efficacy and safety of the neoadjuvant regimen of capecitabine and external beam radiotherapy in combination with panitumumab in patients with advanced K-ras unmutated rectal cancer.

• Country None
• organs None
• Specialty None

Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients PIK3CA mutációs vastagbélrákban szenvedő betegek kiegészítő aszpirin kezelése The objective of the trial is to demonstrate a statistically significant and clinically relevant disease free survival benefit in stage II and III PIK3CA mutated colon cancer patients taking daily adj...

• Country None
• organs None
• Specialty None

Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy The objective of this trial is to study the activity and the safety of the 1st line treatment with Ibrutinib in combination with Rituximab for patients with advanced follicular lymphoma in need of the...

• Country None
• organs None
• Specialty None

SWS-SAKK56/07 : Essai de phase 2 évaluant l'efficacité et la tolérance du dasatinib en traitement de 1ère ligne chez des patients ayant une tumeur stromale gastro-intestinale (GIST). [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] Dasatinib first-line treatment in gastrointestinal stromal tumors. A multi center phase II trial.

• Country France
• organs Tumeurs stromales digestives (GIST)
• Specialty Thérapies Ciblées

Essai de phase 2 évaluant l'efficacité de l'everolimus, chez des patients ayant un lymphome à cellules du manteau en rechute ou résistant aux traitements. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Everolimus (RAD001) for the Treatment of Patients With Relapsed or Therapy Resistant Mantle Cell Lymphoma.

• Country France
• organs Lymphomes non hodgkinien
• Specialty Chimiothérapie

Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced, K-ras mutated rectal cancer. A randomized multicenter phase I/II trial Part I: to determine the recommended dose of the neoadjuvant regimen of capecitabine, sorafenib and external beam radiotherapy in patients with advanced K-ras mutated rectal cancer. Part IIa: to asses...

• Country None
• organs None
• Specialty None

Carboplatin chemotherapy and involved node radiotherapy in stage IIA/B seminoma The main objective of this trial is to test the efficacy and safety of carboplatin chemotherapy and involved node radiotherapy in patients with stage IIA/B seminoma.

• Country None
• organs None
• Specialty None